RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

od Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
Wydane w Exp Mol Pathol (2015)

Epigenetic modifications induced by RGC-32 in colon cancer

od Vlaicu, Sonia I., Tegla, Cosmin A., Cudrici, Cornelia D., Fosbrink, Matthew, Nguyen, Vingh, Azimzadeh, Philippe, Rus, Violeta, Chen, Hegang, Mircea, Petru A., Shamsuddin, Abulkalam, Rus, Horea
Wydane 2009